PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Paradigm on the television ., page-31

  1. 2,465 Posts.
    lightbulb Created with Sketch. 169
    Prior to marketing approval it is wise that Paradigm are not seen as directly promoting PPS in the media like this. Unfortunately, it is also not uncommon to see this type information coming from some unethical companies who use this method to promote worthless products with promises to cure all sorts of devastating diseases by having some bodgy researcher paid to front the camera. Current Affairs programs are notorious for doing this while news services tend to be more prudent in what they air.

    In this case Associate Professor Dr Lara Herrero is an NHMRC research fellow with great credibility and is careful not to overstep the ethical boundaries. The wide coverage given to this report throughout Australia will of course stimulate interest and enquiry that will naturally link the story back to Paradigm. The timing of this report (along with other MPS program announcement) is interesting considering the recent rise in the share price and can only be very positive. It will be interesting to see if the buying momentum keeps going this week.
    Last edited by roboshan: 08/08/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.010(3.77%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $162.7K 620.9K

Buyers (Bids)

No. Vol. Price($)
2 25008 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 34768 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.